Replies to post #250250 on Biotech Values

[DewDiligence]

The biggest problem for the EDP-235 program right now is that people infected with COVID are mostly opting to do nothing and simply let the infection run its course, which is a major change in behavior from 12-24 months ago.

An article in today’s NYT is on-point:

https://www.nytimes.com/2024/01/04/health/paxlovid-covid-treatment.html